Please use this identifier to cite or link to this item: https://doi.org/10.1186/1471-2334-10-44
DC FieldValue
dc.titleGalactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients.
dc.contributor.authorHsu, L.Y.
dc.contributor.authorDing, Y.
dc.contributor.authorPhua, J.
dc.contributor.authorKoh, L.P.
dc.contributor.authorChan, D.S.
dc.contributor.authorKhoo, K.L.
dc.contributor.authorTambyah, P.A.
dc.date.accessioned2016-09-06T08:41:39Z
dc.date.available2016-09-06T08:41:39Z
dc.date.issued2010
dc.identifier.citationHsu, L.Y., Ding, Y., Phua, J., Koh, L.P., Chan, D.S., Khoo, K.L., Tambyah, P.A. (2010). Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients.. BMC infectious diseases 10 : 44-. ScholarBank@NUS Repository. https://doi.org/10.1186/1471-2334-10-44
dc.identifier.issn14712334
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/126814
dc.description.abstractBACKGROUND: Invasive pulmonary aspergillosis (IPA) is a major cause of morbidity and mortality in patients with hematological malignancies in the setting of profound neutropenia and/or hematopoietic stem cell transplantation. Early diagnosis and therapy has been shown to improve outcomes, but reaching a definitive diagnosis quickly can be problematic. Recently, galactomannan testing of bronchoalveolar lavage (BAL) fluid has been investigated as a diagnostic test for IPA, but widespread experience and consensus on optical density (OD) cut-offs remain lacking. METHODS: We performed a prospective case-control study to determine an optimal BAL galactomannan OD cutoff for IPA in at-risk patients with hematological diagnoses. Cases were subjects with hematological diagnoses who met established definitions for proven or probable IPA. There were two control groups: subjects with hematological diagnoses who did not meet definitions for proven or probable IPA and subjects with non-hematological diagnoses who had no evidence of aspergillosis. Following bronchoscopy and BAL, galactomannan testing was performed using the Platelia Aspergillus seroassay in accordance with the manufacturer's instructions. RESULTS: There were 10 cases and 52 controls. Cases had higher BAL fluid galactomannan OD indices (median 4.1, range 1.1-7.7) compared with controls (median 0.3, range 0.1-1.1). ROC analysis demonstrated an optimum OD index cutoff of 1.1, with high specificity (98.1%) and sensitivity (100%) for diagnosing IPA. CONCLUSIONS: Our results also support BAL galactomannan testing as a reasonably safe test with higher sensitivity compared to serum galactomannan testing in at-risk patients with hematological diseases. A higher OD cutoff is necessary to avoid over-diagnosis of IPA, and a standardized method of collection should be established before results can be compared between centers.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1186/1471-2334-10-44
dc.sourceScopus
dc.typeArticle
dc.contributor.departmentMEDICINE
dc.description.doi10.1186/1471-2334-10-44
dc.description.sourcetitleBMC infectious diseases
dc.description.volume10
dc.description.page44-
dc.identifier.isiut000275622900001
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
2010-galactomannan_testing_bronchoalveolar_lavage_fluid-published.pdf806.29 kBAdobe PDF

OPEN

PublishedView/Download

SCOPUSTM   
Citations

44
checked on Nov 19, 2021

WEB OF SCIENCETM
Citations

38
checked on Nov 19, 2021

Page view(s)

283
checked on Nov 18, 2021

Download(s)

3
checked on Nov 18, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.